Cyclodextrins: An overview of the complexation of pharmaceutical proteins

Current Protein and Peptide Science

Volumn 11, Issue 4, 2010, Pages 255-263

  Varca, G H C ^a   Andreo Filho N ^b   Lopes, P S ^b   Ferraz, H G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SOROCABA   (Brazil)

Author keywords

Amino acids; Cyclodextrin; Enzyme; Macromolecules; Peptides; Protein; Supramolecular complexes

Indexed keywords

AMINO ACID; BETA CYCLODEXTRIN DERIVATIVE; CYCLODEXTRIN; ENZYME; PENETRATION ENHANCING AGENT; PEPTIDE; PROTEIN DERIVATIVE; SOLUBILIZER; SOLVENT;

ABSORPTION; AMINATION; ARTICLE; BIOCATALYST; COMPLEX FORMATION; DRUG DELIVERY SYSTEM; ENVIRONMENTAL FACTOR; ESTERIFICATION; ETHERIFICATION; HYDROPHOBICITY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; SHELF LIFE; SUPRAMOLECULAR CHEMISTRY; THERMOSTABILITY;

CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; MACROMOLECULAR SUBSTANCES; PROTEINS;

EID: 77953512339     PISSN: 13892037     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920310791233387     Document Type: Article

References (72)

1. Jones, D.S.; Silverman, A.P.; Cochran, J.R. Developing therapeuticproteins by engineering ligand-receptor interactions. TrendsBiotechnol., 2008, 26, 498-505.
2. Chandel, A.K.; Rudravaram, R.; Rao, L.V.; Pogaku, R.; Narasu,M.L. Industrial enzymes in bioindustrial sector development: anIndian perspective. J. Commun. Biotechnol., 2007, 13, 283-291.
3. Iyer, P. V.; Ananthanarayan, L. Enzyme stability and stabilization-Aqueous and non-aqueous environment. Process Biochem, 2008,doi:10.1016/j.procbio.2008.06.004.
4. Pollizi, K.M.; Bommarius, A.S.; Broering, J.M.; Chaparro-Riggers, J. F.: Stability of biocatalysts. Curr. Opin. Chem. Biol., 2007, 11,220-225.
5. Lad, R.; Biotecnology in personal care. Cosmetic Science andTechnology Series, v29, 2006
6. Martin Del Valle, E.M. Cyclodextrins and their uses: a review.Process Biochem, 2004, 39, 1033-1046.
7. Fernández, M.; Villalonga, M.L.; Fragoso, A.; Cao, R; Baños, M.; Villalonga R. α-Chymotrypsin stabilization by chemicalconjugation with O-carboxymethyl-poly-β-cyclodextrin. ProcessBiochem, 2004, 39, 535-539.
8. Wang, C.; Eufemi, M.; Turano, C.; Giartosio, A. Influence of thecarbohydrate moiety on the stability of glycoproteins.Biochemistry, 1996, 35, 7299-7307.
9. Villalonga, R.; Cao, R.; Fragoso, A. Supramolecular chemistry ofcyclodextrins in enzyme technology. Chem. Rev., 2007, 107, 3088-3116.
10. Dong, X.; Wu, X.; Sun, Y. Refolding of denatured lysozymeassisted by artificial chaperones in reverse micelles. Biochem. Eng.J., 2006, 31, 92-95.
11. Couthon, F.; Clottes, E.; Vial, C. Refolding of SDS- and thermallydenatured MM-creatine kinase using cyclodextrins. Biochem.Biophys. Res. Commun., 1996, 227, 854-860.
12. Breslow, R. Biomimetic chemistry and artificial enzymes: catalysisby design. Acc. Chem. Res., 1995, 28, 146-153.
13. Murakami; Y.; Kikuchi, J.; Hisaeda, Y.; Hayashida, O. ArtificialEnzymes. Chem. Rev., 1996, 96, 721-758.
14. Villalonga, R.; Tachibana, S.; Cao R.; Ramirez, H.L.; Asano, Y. Supramolecular-mediated thermostabilization of phenylalaninedehydrogenase modified with b-cyclodextrin derivatives. Biochem.Eng. J., 2006, 30:26-32.
15. Varca, G. H. C.; Andréo-Filho, N.; Fraceto, L. F.; Kaneko, T. M.; Ferraz, H. G.; Esteves, N. M.; Issa, M. G.; Mathor, M. B.; Lopes, P. S. Thermal characterization and cytotoxicity of complexesformed by papain and cyclodextrin. J. Biol. Phys., 2007, 33, 463-475
16. Izutsu, K.; Yoshioka, S.; Terao, T. Stabilization of P-galactosidaseby amphiphilic additives during freeze-drying. Int. J. Pharm., 1993,90, 187-194.
17. Khodarahmi, R.; Yazdanparast, R. Refolding of chemicallydenatured a-amylase in dilution additive mode. Biochim. Biophys.Acta, 2004, 1674, 175-181.
18. Kamphorst, A.O.; Mendes de Sá, I.; Faria, A.M.C.; Sinisterra, A.M.C. Association complexes between ovalbumin andcyclodextrins have no effect on the immunological properties ofovalbumin. Eur. J. Pharm. Biopharm., 2004, 57, 199-205.
19. Yi, Z.; Qasim, M.A.; Qasim, S.; Warrington, T.L.; Laskowski Jr., M. Ring-Toss: Capping highly exposed tyrosyl or tryptophylVarca et al.residues in proteins with β-cyclodextrin. Biochim. Biophys. Acta, 2006, 1760, 372-379.
20. Tsutsumi, H.; Ikeda, H.; Mihara, H.; Ueno, A. Enantioselectiveester hydrolysis catalyzed by β-cyclodextrin conjugated with -hairpin peptides. Bioorg. Med. Chem. Lett., 2004, 14, 723-726.
21. Nakate, T.; Yoshida, H.; Ohike, A.; Tokunaga, Y.; Ibuki, R.; Kawashima, Y. Improvement of pulmonary absorption ofcyclopeptide FK224 in rats by co-formulating with β-cyclodextrin. Eur. J. Pharm. Biopharm. 2003, 55, 147-154.
22. Dotsikas, Y.; Yannis L. L. Kinetic degradation study of insulincomplexed with methyl-beta cyclodextrin: confirmation ofcomplexation with electrospray mass spectrometry and 1H NMR. JPharm. Biomed. Anal., 2002, 29, 487-494.
23. Sajeesh, S.; Sharma, C.P. Cyclodextrin-insulin complexencapsulated polymethacrylic acid based nanoparticles for oralinsulin delivery. Int. J. Pharm,. 2006, 325, 147-154
24. Higashi, T.; Hirayama, F.; Misumi, S.; Arima, H.; Uekama, K.Design and evaluation of polypseudorotaxanes of pegylated insulinwith cyclodextrins as sustained release system. Biomaterials, 2008,29, 3866-3871.
25. Castronuovo, G.; Elia, V.; Fessas, D.; Giordano, A.; Velleca, F.Thermodynamics of the interaction of cyclodextrins with aromaticand, -amino acids in aqueous solutions: a calorimetric study at25°C. Carbohydr. Res., 1995, 272, 31-39.
26. Barone, G.; Castronuovo, G.; Di Ruocco, V.; Elia, V.; Giancola, C.Inclusion compounds in water: thermodynamics of the interactionof cyclomaltohexaose with amino acids at 25"*. Carbohydr. Res.,1989, 192, 331-341.
27. Rebarsky, M.V.; Schwarz, F.P.; Tewari, Y.B.; Goldberg, R. N. AThermodynamic study of the reactions of cyclodextrins withprimary and secondary aliphatic alcohols, with D- and L-phenylalanine, and with L-phenylalanineamide. J. Phys. Chem.,1994, 98, 10282-10288.
28. Soares, A. F.; Carvalho, R. A; Veiga, F. Oral administration ofpeptides and proteins: nanoparticles and cyclodextrins asbiocompatible delivery systems. Nanomedicine, 2007, 2, 183-202.
29. Marcato, P. D.; Duran, N. New aspects of nanopharmaceuticaldelivery systems. J. Nanosci. Nanotechnol., 2008, 8, 2216-2229.
30. Irie, T.; Uekama, K. Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev., 1999, 36, 101-123.
31. Uekama, K.; Hirayama, F; Irie, T. Cyclodextrin drug carriersystems. Chem Rev., 1998, 98, 2045-2076.
32. Uekama, K. Pharmaceutical application of cyclodextrins as multi-functional drug carriers. Yakugaku Zasshi., 2004, 12, 909-935.
33. Uekama, K. Recent aspects of pharmaceutical application ofcyclodextrins. J. Inclusion Phenom. Macrocycl. Chem., 2002, 44,3-7.
34. Singh; M.; Rohit Sharma, R.; Banerjee, U.C. Biotecnologicalapplications of cyclodextrins. Biotecnol. Adv., 2002, 20, 341-359.
35. Szetjli J. Introduction and general overview of cyclodextrinchemistry. Biotechnol. Adv., 1994, 12, 325-339.
36. Eastburn, S.D.; Tao, B.Y.; Applications of modified cyclodextrins.Biotechnol. Adv. 1994, 12, 235-239.
37. Venema, A.; Henderiks, H.; Geest, R. V. The enantioselectivity ofmodified cyclodextrin: studies on interaction mechanisms, J. HighResolut. Chromatogr., 1991, 14, 676-680.
38. Atwood JL. Inclusion phenomenon and molecular recognition.New York: Plenum, 1990.
39. Dill, K. A.; Banu Ozkan, S.; Scott Shell, M.; Weikl, R.T. Theprotein folding problem. Annu. Rev. Biophys., 2008, 37, 289-316.
40. Bell, L. N. Peptide stability in solids and solutions. Biotechnol.Prog., 1997, 13, 342-346.
41. Sayani, A.P.; Chien, Y.W. Systemic delivery of peptides andproteins across absorptive mucosae, CRC Crit. Rev. Ther. DrugCarrier Syst., 1996, 13, 85-184.
42. Powell, M. F. Peptide Stability in Aqueous ParenteralFormulations. In Formulation and Delivery of Proteins andPeptides; Cleland, J. L., Langer, R.; Eds.; American ChemicalSociety: Washington, DC, 1994; 100-117.
43. Geigert, J. Overview of the stability and handling of recombinantprotein drugs. J. Parenter. Sci. Technol., 1989, 43, 220-224.
44. Challa, R.; Ahuja, A.; Ali, J.; Khar, R.K. Cyclodextrins in DrugDelivery: an updated review. AAPS PharmSciTech, 2005, 6, 329-357.
45. J. Horsky, J. Pitha, Inclusion complexes of proteins: Interaction ofcyclodextrins with peptides containing aromatic amino acids Cyclodextrinsstudied by competitive spectrophotometry, J. Inclusion Phenom.Mol. Recognit. Chem, 1994. 18, 291-300.
46. Ionov, R.; Hédoux, A.; Guinet, Y.; Bordat, P.; Lerbret, A.; Affouard, F.; Prevost, D.; Descamps, M. Sugar bioprotectiveeffects on thermal denaturation of lysozyme: insights from Ramanscattering experiments and molecular dynamics simulation. J. Non-Crystalline Solids, 2006, 352, 4430-4436.
47. Brewster, M. E.; Loftsson T.;. Cyclodextrins as pharmaceuticalsolubilizers. Adv. Drug Deliv. Rev., 2007, 59, 645-666.
48. Stella, V. J.; Rao, V. M.; Zannou, E. A.; Zia, V. Mechanisms ofdrug release from cyclodextrins complexes. Adv. Drug Deliv. Rev.,1999, 36, 3-1.
49. López-Díez, E. C.; Bone, S. The interaction of trypsin withtrehalose: an investigation of protein preservation mechanisms.Biochim. Biophys. Acta, 2004, 1673, 139-148.
50. Saenger, W.; Noltemeyer, M.; Manor, P. C.; Hingerty, B.; Klar, B."Induced-Fit"-type complex formation of the model enzyme α-cyclodextrin. Bioorg. Chem., 1976, 5, 187-195.
51. Liu, L.; Guo, Qing-Xiang. The Driving Forces in the InclusionComplexation of Cyclodextrins. J. Inclusion Phenom. Macrocycl.Chem., 2002, 42, 1-14.
52. W. Kauzman. Some factors in the interpretation of proteindenaturation. Adv. Protein Chem., 1959, 14, 1-63.
53. Liu, Y.; Zhang, M.; Qi, A.D.; Chen, R.-T.; Yamamoto, K.; Wada, T.; Inoue, Y. Molecular recognition study on a supramolecularsystem. 10. Inclusion complexation of modified b-cyclodextrinswith amino acids: enhanced enantioselec-tivity for L /D-leucine, J.Org. Chem.,1997, 62, 1826-1830.
54. Inoue, Y; Miyata, Y. Formation and molecular dynamics ofcycloamylose inclusion complexes with phenylalanine. Bull. Chem.Soc. Jpn., 1981, 54, 809-816.
55. Tavornvipas, S.; Hirayama, F.; Takeda, S.; Arima, H.; Uekama, K. Effects of cyclodextrins on chemically and thermally inducedunfolding and aggregation of lysozyme and basic fibroblast growthfactor. J. Pharm. Sci., 2006, 95, 2722-2729.
56. Haeberlin, B.; Gengenbacher, T.; Meinzer, A.; Fricker, G.Cyclodextrins Useful excipients for oral peptide administration?.Int. J. Pharm., 1996, 137, 103-110.
57. Sathish, H.A.; Kumar, P. R.; Prakash, V. Mechanism of solventinduced thermal stabilization of papain. Int. J. Biol.Macromol.,2007, 41, 383-390.
58. Lee, J.C.; Timasheff, S.N. The stabilization of proteins by sucrose.J. Biol. Chem., 1981, 256, 7193-7201.
59. Arakawa, T.; Timasheff S.N.: Stabilization of protein structure bysugars. Biochemistry, 1982, 21, 6536-6544.
60. Cunha-Filho, M.S.S.; Sá-Barreto, L.C.L. Utilização deciclodextrinas na formação de complexos de inclusão de interessefarmacêutico. J. Basic Appl. Pharm. Scien., 2007, 28, 1-9.
61. Palmeiri, G.F; Angeli, D.G.; Giovannnucci, G.; Martelli S.Inclusion of methoxytropate in and hydroxylpropyl β-cyclodextrins: Comparision of preparation methods. Drug Dev. Ind.Pharm., 1997, 23, 27-37.
62. Pitha, J.; Hoshino, T.; Torres-Labandeira, J.; Trie T. Preparation ofdrug-hydroxipropyl cyclodextrins complexes by a method usingethanol or aqueous ammonium hydroxide as cosolubilizers. Int. J.Pharm, 1992, 80, 253-258.
63. Matsubara, K.; Abe, K.; Irie, T.; Uekama, K. Improvement of nasalbioavailability of luteinizing hormone-releasing hormone agonist,buserelin, by cyclodextrin derivatives in rats, J. Pharm, Sci., 1995,84, 1295-1300.
64. Verhoef, J. C.; Schipper, N. G.M.; Romeijn, S. G.; F. W.H.M. Merkus. The potential of cyclodextrins as absorption enhancers innasaldelivery of peptide drugs. J. Control Release, 1994, 29, 351-360.
65. Yaksh, T. L.; Jang, J.; Nishiuchi, Y.; Braun, K. P.; Ro, S.; Goodman, M. The utility of 2-hydroxypropyl-β-cyclodextrin as avehicle for the intracerebral and intrathecal administration of drugs. Life Sci., 1991, 48, 623-633.
66. Quang, C.; Malek, A.; Khaledi, M. G. Separation of peptides andproteins by capillary electrophoresis using acidic buffers containingtetraalkylammonium cations and cyclodextrins. Electrophoresis,2003, 24, 824-828.
67. Kano, K. Mechanisms for chiral recognition by cyclodextrins. J.Phys. Org. Chem., 1997, 10, 286-291.
68. Rathore, A.S.; Horváth, Cs. Cyclodextrin aided separation ofpeptides and proteins by capillary zone electrophoresis. J.Chromatogr. A, 1998, 796, 367-373.
69. Karuppiah, N.; Sharma, A. Cyclodextrins as protein folding aids.Biochem. Biophys. Res. Commun., 1995, 211, 60-66.
70. Rozema, D.; Gellman, S.H. Artificial chaperones: protein refoldingvia sequential use of detergent and cyclodextrin. J. Am. Chem. Soc.,1995, 117, 2373-2374.
71. Loretta S.L.; Sharma, A. Influence of cyclodextrin ring substituentson folding-related aggregation of bovine carbonic anhydrase. Eur.J. Biochem., 2001, 268, 2456-2463.
72. Villalonga, R.; Fernández, M.; Fragoso, A.; Cao, R.; Mariniello, L.; Porta, R. Thermal stabilization of trypsin by enzymic modificationwith β-cyclodextrin derivatives. Biotechnol. Appl. Biochem., 2003,38, 53-59.